Page last updated: 2024-11-06

violuric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

violuric acid: an antihypoxic agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66599
SCHEMBL ID89290
SCHEMBL ID11073630
MeSH IDM0248413

Synonyms (45)

Synonym
alloxan-5-oxime
einecs 201-741-4
nsc 56338
2,4,5,6(1h,3h)-pyrimidinetetrone, 5-oxime
5-hydroxyiminobarbituric acid
5-isonitrosobarbituic acid
5-hydroxyiminohexahydropyrimidine-2,4,6-trione
wln: t6mvmvyvj eunq
nsc56338
2,5,6(1h,3h)-pyrimidinetetrone, 5-oxime
violuric acid
alloxan, 5-oxime
5-isonitrosobarbituric acid
5-(hydroxyimino)barbituric acid
nsc-56338
alloxan 5-oxime
87-39-8
A0217
A842126
5-hydroxyimino-1,3-diazinane-2,4,6-trione
05rfr8ac84 ,
unii-05rfr8ac84
AKOS006227647
AKOS015902371
5-(hydroxyimino)-1,3-diazinane-2,4,6-trione
violuric acid [mi]
2,4,5,6(1h,3h)-pyrimidinetetrone 5-oxime
FT-0620525
5-(hydroxyimino)pyrimidine-2,4,6(1h,3h,5h)-trione
SCHEMBL89290
AKOS025255608
SCHEMBL11073630
DTXSID8058954
BBL035366
STL415951
(5e)-2,6-dihydroxy-5-(hydroxyimino)pyrimidin-4(5h)-one
6-hydroxy-5-nitroso-1h-pyrimidine-2,4-dione
5-nitrosopyrimidine-2,4,6-triol
mfcd00006032
DS-13189
STL182763
Q27236132
CS-0149651
HY-W097009
EN300-43354346

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (9.52)18.2507
2000's8 (38.10)29.6817
2010's9 (42.86)24.3611
2020's2 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.03 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]